Petros Grivas
@PGrivasMDPhD
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine
#TumorBoardTuesday ☑️The Tx of EARLY stage bladder Ca is getting better maybe with⬆️cure rates🙏 📢Join us Tuesday, July 29 at 8PM ET as @DrYukselUrun & @yekeduz_emre🗣️best practices in neoadj & perioperative tx of MIBC #bladdercancer RT and bring others into the discussion‼️
📣 𝕏 Post of the Day (July 26, 2025) Dr. Yüksel Ürün, MD (@DrYukselUrun) shares a key update on KEYNOTE-B61: First-line Pembrolizumab Plus Lenvatinib for Advanced Non-clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial 🔗 Learn more about…
One of our stellar @ASCO LDP mentees this year, @NiuSanford @utswcancer, has put together a phenomenal series of online lectures on @YouTube (totally free!) detailing different aspects of #radonc. There is certainly some focus on GI onc, her specialty, but I think every #hemeonc…
After spending time w yet another amazing @ASCO LDP class (my small group: @nabiladra, @umangtalking, #DrRebeccaSnyder, #DrCiaraOSullivan), capitalized on @NRGonc happening in the DC area & met up w former LDP classmate @ndenduluri1, former LDP mentees @shilpaonc & @StephenChunMD…
Join @CParkMD & me on Dec 13 in Seattle for a fantastic Master Lectures series with stellar speakers, interactions, fun! Register below: masterlectureseries.com/registration-m… @PavlosMsaouel @mshadman @RahulBanerjeeMD @DRBakaloudiMD @DMakrakisMD @HsiehLab @DimaDanai @fredhutch @DrOmarMian
Breaking news👉Glad to report the news from ph3 Contact-2 trial👉Cabozantinib + atezolizumab significantly improve outcomes in mCRPC #prostatecancer .Trial description from @ASCO TIP abstract 👇Press release: shorturl.at/cCQY4 @montypal @OncoAlert @urotoday @PCF_Science
A warm invite to all of our GU Colleagues to attend IN PERSON OR ONLINE (HYBRID) To the International Urology Cancer Summit🇬🇧 in Portsmouth!! REGISTER HERE👉 buff.ly/ahAjiFj The International Urology Cancer Summit is a free, independent educational event for all…
Always a privilege to meet @montypal and learn from his incredible wisdom and experience. Having him as a mentor in the @ASCO LDP is truly a dream come true.
fantastic to have @UroDocAsh a phenomenal leader in the field! Love the pics! @CityofHope_GU @AbhiTrip87 @TDorffOnc @IBCG_BladderCA @BladderCancerUS @WorldBladderCan @montypal @SpiessPhilippe @AndreaNecchi @shilpaonc @karima_oualla @MDAndersonNews @PavlosMsaouel @UrogerliMD
A huge honor to have @UroDocAsh @MDAndersonNews visit us at @cityofhope! As we continue to grow our program, awesome to get feedback & advice from a leader in the field! @BladderCancerUS @PGrivasMDPhD @AndreaNecchi
Amazing news! Congratulations @DrRanaMcKay
Could not think of a better person to take on this tremendous role for this @AmericanCancer journal! Congrats @DrRanaMcKay! @DrChoueiri @BradMcG04 @shilpaonc @VivekSubbiah @neerajaiims @PGrivasMDPhD
Some neat work from @ErnstLengyel and team contributing to understanding the interface of immune response and suppressive TME/cancer-associated fibroblasts in @Nature @UofC nature.com/articles/s4158…
The @ASCO International Clinical Research Scholars (ICRS), led by ASCO Asia Pacific Regional Council encourages the development of cancer research across the region: Apply now! asco.smapply.org/prog/ICRS_Asia…
Thanks @DrKatyMoore @PTarantinoMD for organizing such a state of the art session on everything about ADCs across solid tumors and the invite to talk about ADCs in GU cancers! What an incredible session with an all ⭐️ faculty with the best part being the realistic and poignant…
Incredibly proud and grateful for the success of this @NRGonc ADC Symposium in DC! Packed room, outstanding talks from all faculty, and plenty of food for thought to push forward the field of ADC across oncology fields.
Awesome to see @DrEdKim @cityofhopeoc at #BTGlung2025, chaired by @NarjustFlorezMD @DanaFarber. Hear more about what inspired Dr. Kim in his journey towards a career in #oncology on the @cityofhope podcast below 👇@jdoningtonmd @TejasPatilMD @ChristineBestv1 @BalazsHalmosMD…
Following the standard of care won't get the job done against cancer. @montypal and @DrEdKim, physician-in-chief @cityofhopeoc, discuss why in the latest “On the Edge of Breakthrough: Voices of Cancer Research” #podcast episode. Listen: spoti.fi/4hOfEJV
Dr. @PatelOncology offers his thoughts on the 1L management of mNSCLC BOOKMARK this slide. #BTGLung2025 @OncLive @NarjustFlorezMD @DrEdKim
Radiation vs systemic therapy for isolated pelvic recurrence after cystectomy. @AndreaNecchi & Comron Hassanzadeh join @UroDocAsh in a debate about optimal management of isolated pelvic recurrences after radical cystectomy. #WatchNow on UroToday > bit.ly/45e2hPP
Impressed with amazing team spirit, hard work, collaboration, dedication of National Greek team of waterpolo! Congrats on world championship! @DrYukselUrun @koshkin85 @DMakrakisMD @DRBakaloudiMD @pdzavras @minaseconomides @LeonidasPlatan1 @EAntonarakis @mtsiatas @PavlosMsaouel
GREECE ARE WORLD CHAMPIONS!!! 🇬🇷🇬🇷🇬🇷 📸 MTB Photos / Albert ten Hove #waterpolo360 #waterpolo #vaterpolo #vizilabda #pallanuoto #wasserball
The paper @JCOOP_ASCO @JCO_ASCO @ASCO Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice @OncoAlert @Dr_R_Kurzrock ascopubs.org/doi/10.1200/OP…
15/15 🎯 Call to action: Oncologists: Order NGS for ALL rare cancer patients Payers: Cover comprehensive profiling Patients/families: Advocate for testing Researchers: Continue building the evidence Every rare cancer patient deserves precision medicine! 🧬💙…
14/15 💪 Bottom line: Comprehensive molecular profiling isn't just "nice to have" - it's an IMPERATIVE for rare cancer patients. It's their pathway to: Accurate diagnosis Targeted therapies Clinical trials Hope for better outcomes ascopubs.org/doi/10.1200/JC…